Compile Data Set for Download or QSAR
Report error Found 735 Enz. Inhib. hit(s) with Target = 'Peptidyl-prolyl cis-trans isomerase A'
TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM172717(US9090657, 24)
Affinity DataIC50: 0.310nMAssay Description:The PPlase activity of recombinant CypA or D, produced by thrombin cleavage of GST-CypA or D, was determined by following the rate of hydrolysis of N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2016
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM50339127((3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-d...)
Affinity DataKi:  0.340nMAssay Description:Inhibition of human recombinant cyclophilin-associted cis-trans propyl isomerase activityMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2011
Entry Details Article
PubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286596(US9566312, Compound 2.17.14)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286543(US9566312, Compound 2.5.24)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286569(US9566312, Compound 2.8.8)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286585(US9566312, Compound 2.17.3)
Affinity DataKd:  0.5nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286583(US9566312, Compound 2.17.1)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286608(US9566312, Compound 2.19.4)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286568(US9566312, Compound 2.8.7)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286584(US9566312, Compound 2.17.2)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286592(US9566312, Compound 2.17.10)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286566(US9566312, Compound 2.8.5)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286570(US9566312, Compound 2.8.9)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM50030493(CHEMBL3344501 | US9566312, Compound 2.17.4)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286615(US9566312, Compound 2.20.2)
Affinity DataKd:  0.600nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286587(US9566312, Compound 2.17.5)
Affinity DataKd:  0.700nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286551(US9566312, Compound 2.5.32)
Affinity DataKd:  0.700nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286609(US9566312, Compound 2.19.5)
Affinity DataKd:  0.700nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286610(US9566312, Compound 2.19.6)
Affinity DataKd:  0.700nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286614(US9566312, Compound 2.20.1)
Affinity DataKd:  0.700nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM285708(US10077289, Compound 16 | [(2S,3R,4R)-3-Hydroxy-4-...)
Affinity DataKi:  0.720nMpH: 7.8Assay Description:The protease-free PPIase assay measures the rate of cis to trans conversion of a peptide substrate catalyzed by the enzyme cyclophilin A. Addition of...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286612(US9566312, Compound 2.19.8)
Affinity DataKd:  0.800nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286613(US9566312, Compound 2.19.9)
Affinity DataKd:  0.800nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286528(US9566312, Compound 2.5.9)
Affinity DataKd:  0.800nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM172715(US9090657, DEBIO-025, 2)
Affinity DataIC50: 0.800nMAssay Description:The PPlase activity of recombinant CypA or D, produced by thrombin cleavage of GST-CypA or D, was determined by following the rate of hydrolysis of N...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2016
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286607(US9566312, Compound 2.19.3)
Affinity DataKd:  0.800nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286591(US9566312, Compound 2.17.9)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286588(US9566312, Compound 2.17.6)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286601(US9566312, Compound 2.18.5)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286605(US9566312, Compound 2.19.1)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286532(US9566312, Compound 2.5.13)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286565(US9566312, Compound 2.8.4)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286573(US9566312, Compound 2.9)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286602(US9566312, Compound 2.18.8)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286606(US9566312, Compound 2.19.2)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286599(US9566312, Compound 2.18.3)
Affinity DataKd:  0.900nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286555(US9566312, Compound 2.6.1)
Affinity DataKd:  1nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286531(US9566312, Compound 2.5.12)
Affinity DataKd:  1nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286533(US9566312, Compound 2.5.15 | US9566312, Compound 2...)
Affinity DataKd:  1nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286582(US9566312, Compound 2.16)
Affinity DataKd:  1nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM50030494(CHEMBL3344503)
Affinity DataKd:  1.10nMAssay Description:Binding affinity to human cyclophilin A by surface plasmon resonance methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286552(US9566312, Compound 2.5.33)
Affinity DataKd:  1.10nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286590(US9566312, Compound 2.17.11 | US9566312, Compound ...)
Affinity DataKd:  1.10nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286598(US9566312, Compound 2.18.2)
Affinity DataKd:  1.10nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM50030533(CHEMBL3344502)
Affinity DataKd:  1.10nMAssay Description:Binding affinity to human cyclophilin A by surface plasmon resonance methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2016
Entry Details Article
PubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286611(US9566312, Compound 2.19.7)
Affinity DataKd:  1.10nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286600(US9566312, Compound 2.18.4)
Affinity DataKd:  1.20nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM761597(US20250243219, Compound 42)
Affinity DataIC50: 1.20nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM286529(US9566312, Compound 2.5.10)
Affinity DataKd:  1.20nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetPeptidyl-prolyl cis-trans isomerase A(Human)
Neurovive Pharmaceutical

US Patent
LigandPNGBDBM50030555(CHEMBL3344493 | US9566312, Compound 2.10)
Affinity DataKd:  1.20nMpH: 7.4Assay Description:Binding of inhibitors to expressed cyclophilins was determined using surface plasmon resonance (SPR) experiments. Briefly, avi-tagged cyclophilin pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

Displayed 1 to 50 (of 735 total ) | Next | Last >>
Jump to: